Paradromics - About the company
Paradromics is a series A company based in Austin (United States), founded in 2015 by Andreas Schaefer, Matt Angle and Edmund Huber. It operates as a Provider of data streaming brain-computer interfaces. Paradromics has raised $88.7M in funding from investors like Prime Movers Lab, Synergy Ventures and Arkitekt Ventures, with a current valuation of $*****. The company has 9 active competitors, including 7 that are funded. Its top competitors include companies like Neuralink, Synchron and CorTec.
Company Details
Provider of data streaming brain-computer interfaces. Its neural-machine interfaces facilitate data transmission between the brain and machines to assist in the treatment of neurodegenerative diseases. It is making high-volume bidirectional data streaming capabilities, that can enable a disabled person to connect to the outer world. Its implanted electrodes will send and receive signals from the brain to the sensor enabling prosthetic devices.
- Website
- www.paradromics.com/
- Email ID
- *****@paradromics.com
Key Metrics
Founded Year
2015
Location
Austin, United States
Stage
Series A
Total Funding
$88.7M in 13 rounds
Latest Funding Round
Post Money Valuation
$***** as on Nov 25, 2025
Investors
Ranked
3rd among 9 active competitors
Employee Count
123 as on Aug 31, 2026
Sign up to download Paradromics' company profile
Paradromics's funding and investors
Paradromics has raised a total funding of $88.7M over 13 rounds. Its first funding round was on Aug 03, 2015. Its latest funding round was a Series A round on Feb 12, 2025 for $*****. 1 investor participated in its latest round. Paradromics has 31 institutional investors.
Here is the list of recent funding rounds of Paradromics:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Feb 12, 2025 | 2057376 | Series A | 1101582 | 3193682 | 4255528 | 9898053 |
Feb 05, 2025 | 3493102 | Grant (prize money) | 4835217 | 2869340 | 1410281 | |
Nov 01, 2023 | 6654897 | Series A | 4392834 | 5133649 | 3613998 | 2180361 |
View details of Paradromics's funding rounds and investors
Paradromics' founders and board of directors
Founder? Claim ProfileHere are the details of Paradromics' key team members:
- Andreas Schaefer: Co-Founder of Paradromics.
- Matt Angle: Co-Founder & CEO of Paradromics. Contact Info: 1 email address
- Edmund Huber: Co-Founder of Paradromics. Contact Info: 1 email address
View details of Paradromics's Founder profiles and Board Members
Paradromics' employee count trend
Paradromics has 123 employees as of Aug 26. Here is Paradromics's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Paradromics's Competitors and alternates
Top competitors of Paradromics include Neuralink, Synchron and CorTec. Here is the list of Top 10 competitors of Paradromics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Neuralink 2016, Fremont (United States), Series E | Provider of implantable brain-computer interfaces | $1.29B | 66/100 | |
2nd | Synchron 2016, Brooklyn (United States), Series D | Developer of implantable bioelectronics for the treatment of neurological conditions | $345M | 62/100 | |
3rd | Paradromics 2015, Austin (United States), Series A | Provider of data streaming brain-computer interfaces | $88.7M | 59/100 | |
4th | Manufacturer of active implantable neurotechnology devices, components, and sub-assemblies | $21.6M | 57/100 | ||
5th | Inner Cosmos 2017, Portola Valley (United States), Seed | Provider of AI-based device for treating mood and addiction disorders | $11.9M | 39/100 | |
6th | NeuralPort 2020, Kyoto (Japan), Seed | Provider of brain-computer interface and neurotechnology solutions | $1.06M | 26/100 | |
7th | BrainGate 2004, Glendale (United States), Funding Raised | Medical research developing brain-computer interfaces for people with paralysis | - | 19/100 | |
8th | Novum 2014, Gaithersburg (United States), Deadpooled | Thought Recognition technology | - | - | 15/100 |
9th | Parasma 2026, San Francisco (United States), Seed | Platform utilizing human brain cells for AI computing purposes | $500K | 15/100 | |
10th | Prior AI Computers Cambridge (United States), Funding Raised | Developer of artificial intelligence systems based on cognitive science principles | - | 15/100 |
Looking for more details on Paradromics's competitors? Click here to see the top ones
Paradromics's Investments and acquisitions
Paradromics has made no investments or acquisitions yet.
Reports related to Paradromics
Here is the latest report on Paradromics's sector:
News related to Paradromics
Media has covered Paradromics for a total of 7 events in the last 1 year, 2 of them have been about company updates and 2 about people movement.
•
Paradromics Achieves Real-Time Speech with Connexus® Brain-Computer InterfaceBusiness Wire•Sep 15, 2026•Paradromics
•
William J. Marks Jr. Joins Paradromics as Chief Clinical OfficerMedical Product Outsourcing•Sep 12, 2026•Paradromics
•
Paradromics Gets FDA OK to Expand BCI Access to Personal DevicesMedical Product Outsourcing•Aug 28, 2026•Paradromics
•
Paradromics Appoints William J. Marks, Jr., MD, MS-HCM, as Chief Clinical OfficerYahoo•Jul 07, 2026•Paradromics
•
Paradromics and University of Michigan Complete First Connexus® BCI Implantation for the FDA-Approved Connect-One Clinical StudyBusiness Wire•Jun 17, 2026•Paradromics
•
Paradromics Unveils APEX Partnership Program to Boost Neurotechnology DiscoveryMedical Product Outsourcing•Mar 27, 2026•Paradromics
•
Paradromics Receives FDA Approval for the Connect-One Clinical Study with the Connexus® Brain-Computer InterfaceBusiness Wire•Nov 20, 2025•Paradromics
•
Neuralink competitor Paradromics completes first human implant of Connexus brain-computer interface.FOX Business•Jun 03, 2025•Paradromics
•
NEOM partners with Paradromics to drive innovation in neurotech healthcare in Saudi ArabiaBioSpectrum Asia•Feb 17, 2025•Neom, Paradromics
•
NEOM Investment Fund partners with Paradromics to drive innovation in neurotechnology healthcarePR Newswire•Feb 12, 2025•Neom, Paradromics
Are you a Founder ?
FAQs about Paradromics
Explore our recently published companies
- Viet Tiles - Ho Chi Minh City based, Unfunded company
- Mile Twenty Six - 2002 founded, Unfunded company
- VousVous - 2026 founded, Unfunded company
- 7X Weddings - Ahmedabad based, Unfunded company
- Fabcart - Unfunded company
- Zearch - United Kingdom based, 2019 founded, Unfunded company